SCHEMBL25019973

SCHEMBL25019973

CCc1c(C)nc(OC[C@@H]2C[C@@H](OC)CN2C)nc1N(CC)CCCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21896269 0.83 CHRNB2 (0.36) —
SCHEMBL21912065 0.78 KDM4E (0.34) —
SCHEMBL22994752 0.76 KDM4E (0.35) —
SCHEMBL19637446 0.76 KDM4E (0.36) —
SCHEMBL22994768 0.74 KDM4E (0.32) —
SCHEMBL19636821 0.74 KDM4E (0.37) —
SCHEMBL21912138 0.72 CHRNB2 (0.40) —
SCHEMBL22994676 0.71 KDM4E (0.34) —
SCHEMBL22086716 0.69 CHRNB2 (0.44) —
SCHEMBL19637398 0.68 CSF1R (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback